> after years of work, BioNTech says that they can get it down to less than $100,000/dose. I'm sure it can be driven down further, but this is highly unlikely to ever be cheap. They also got an anti-PD-L1 antibody and a four-component chemotherapy cocktail (those last two have already been tried in PDAC therapy without the vaccine dose, to unimpressive effect). The vaccine was administered across nine doses
Wow, $1mm to save a life. (This math works in the rich world.)
Wow, $1mm to save a life. (This math works in the rich world.)